OptiNose (Germany) Analysis
| 0OP Stock | EUR 0.38 0.01 2.70% |
OptiNose is fairly valued with Real Value of 0.37 and Hype Value of 0.38. The main objective of OptiNose stock analysis is to determine its intrinsic value, which is an estimate of what OptiNose is worth, separate from its market price. There are two main types of OptiNose's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect OptiNose's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of OptiNose's stock to identify patterns and trends that may indicate its future price movements.
The OptiNose stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and OptiNose's ongoing operational relationships across important fundamental and technical indicators.
OptiNose |
OptiNose Stock Analysis Notes
About 78.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.86. OptiNose had not issued any dividends in recent years. The entity had 15:1 split on the 30th of September 2024. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people. For more info on OptiNose please contact Peter Miller at 267 364 3500 or go to https://www.optinose.com.OptiNose Investment Alerts
| OptiNose is not yet fully synchronised with the market data | |
| OptiNose is way too risky over 90 days horizon | |
| OptiNose has some characteristics of a very speculative penny stock | |
| OptiNose appears to be risky and price may revert if volatility continues | |
| OptiNose has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 74.65 M. Net Loss for the year was (82.3 M) with profit before overhead, payroll, taxes, and interest of 65.5 M. | |
| OptiNose has accumulated about 93.92 M in cash with (76.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 78.0% of the company shares are owned by institutions such as pension funds |
OptiNose Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 187.86 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OptiNose's market, we take the total number of its shares issued and multiply it by OptiNose's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.OptiNose Profitablity
OptiNose's profitability indicators refer to fundamental financial ratios that showcase OptiNose's ability to generate income relative to its revenue or operating costs. If, let's say, OptiNose is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, OptiNose's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of OptiNose's profitability requires more research than a typical breakdown of OptiNose's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.97) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.76. OptiNose Outstanding Bonds
OptiNose issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OptiNose uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OptiNose bonds can be classified according to their maturity, which is the date when OptiNose has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| US68404LAA08 Corp BondUS68404LAA08 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
OptiNose Predictive Daily Indicators
OptiNose intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OptiNose stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About OptiNose Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OptiNose prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OptiNose shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OptiNose. By using and applying OptiNose Stock analysis, traders can create a robust methodology for identifying OptiNose entry and exit points for their positions.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. OPTINOSE INC operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 204 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding OptiNose to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Complementary Tools for OptiNose Stock analysis
When running OptiNose's price analysis, check to measure OptiNose's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OptiNose is operating at the current time. Most of OptiNose's value examination focuses on studying past and present price action to predict the probability of OptiNose's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OptiNose's price. Additionally, you may evaluate how the addition of OptiNose to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |